Validation of the Eyerobo FC Portable Fundus Camera for Diabetic Retinopathy Screening Using Public Datasets and Deep Learning [0.03%]
基于公共数据集和深度学习验证Eyerobo FC便携式眼底照相机糖尿病视网膜病变筛查效果
Emmanuel Eric Pazo,Xiangying Liu,Shoukuan Liu et al.
Emmanuel Eric Pazo et al.
Introduction: To validate the diagnostic performance of the Eyerobo FC, a new portable non-mydriatic fundus camera for diabetic retinopathy (DR) screening, against an established desktop fundus camera benchmark using a tr...
Tomographic and Biomechanical Stability of the Non-operated Eye in Asymmetric Keratoconus with Unilateral Intracorneal Ring Segment Implantation [0.03%]
单侧角膜环段植入治疗不对称性 keratoconus 的非手术眼层析成像和生物力学稳定性研究
João A Ambrósio,Júlio Brissos,Gonçalo C Tardão et al.
João A Ambrósio et al.
Introduction: This study aimed to assess the tomographic and biomechanical progression of non-operated eyes in patients with asymmetric keratoconus who underwent unilateral intracorneal ring segment (ICRS) implantation. ...
Tariq M Aslam,Focke Ziemssen,Anat Loewenstein et al.
Tariq M Aslam et al.
Receiving a diagnosis of a vision-threatening eye condition is a psychologically salient event for many patients. Across ophthalmology, fear, uncertainty, and emotional distress are commonly observed at the time of diagnosis, often before s...
Influence of Ocular Biometric Parameters on IOL Power Calculation Accuracy in Short and Normal Axial Length Eyes [0.03%]
眼轴较短及正常长度眼球影响人工晶状体计算准确性的屈光参数因素分析
Yuye Zhang,Shiyu Tang,Zihan Xie et al.
Yuye Zhang et al.
Introduction: The aim of this study was to assess the effect of including lens thickness (LT) in modern intraocular lens (IOL) formulas and evaluate the influence of ocular biometric parameters on IOL power calculation ac...
Artificial Intelligence in Vitreoretinal Surgery: A Systematic Review of Current Applications and Future Directions [0.03%]
玻璃体视网膜手术中人工智能的当前应用和未来发展方向系统性综述
Enrico Bernardi,Lorenzo Ferro Desideri,Neil Shah et al.
Enrico Bernardi et al.
Introduction: To examine the current landscape of artificial intelligence (AI) applications in vitreoretinal (VR) diseases and surgery, with the aim of identifying knowledge gaps and guiding future directions in this rapi...
Real-World Performance and Safety of VISIOL in Modern Routine Cataract Surgery [0.03%]
VISIOL在现代白内障手术中的临床表现和安全性评估
Kulawan Rojananuangnit,Thanapong Somkijrungroj,Teeravee Hongyok et al.
Kulawan Rojananuangnit et al.
Introduction: Cataract surgery requires ophthalmic viscosurgical devices (OVDs) to stabilise the anterior chamber and protect the corneal endothelium during phacoemulsification. VISIOL, a viscoadaptive OVD containing sodi...
Comparing Efficacy and Corneal Biomechanics Between KLEx and KLEx Xtra in High Myopia: A 1-Year Prospective Randomized Study [0.03%]
高近视中KLEx和KLEx Xtra的疗效及角膜生物力学对比：一项为期一年的前瞻性随机研究
Jing Cong,Xueqi Lin,Jiayue Yuan et al.
Jing Cong et al.
Introduction: This work aims to compare the 12-month changes in refractive outcomes, safety, efficacy, predictability, corneal biomechanics, and corneal topography between keratorefractive lenticule extraction (KLEx) and ...
One-Year Real-World Outcomes of Switching to Aflibercept 8 mg in Eyes with Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network Report [0.03%]
阿柏西普8毫克治疗湿性年龄相关性黄斑变性的现实世界一年期随访结果：瑞士视网膜研究网络报告
Alice M Kitay,Anne Tillmann,Isabel Pfister et al.
Alice M Kitay et al.
Introduction: This multicenter, longitudinal, observational real-world study evaluated the efficacy and safety of switching to intravitreal aflibercept 8 mg (Afl 8) in pretreated eyes with neovascular age-related macular ...
Prevalence and Risk Factors of Ocular Hypertension Following Fluocinolone Acetonide (Iluvien®) Intravitreal Injections: The "SAFAC" Study [0.03%]
“SAFAC”研究：氟轻松玻璃体内植入术后高眼压的患病率及其危险因素
Yasmine Serrar,Lucas Sejournet,Benoît Allignet et al.
Yasmine Serrar et al.
Introduction: The aim of this real-life study was to analyze the prevalence and risk factors of ocular hypertension (OHT) after fluocinolone acetonide implant (FAc-I) intravitreal injections in the treatment of macular ed...
Correction: One-Year Outcomes of Faricimab in Treatment-Naïve Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network Report [0.03%]
法瑞西玛针对既往未接受治疗的湿性年龄相关性黄斑变性的疗效：瑞士视网膜研究网络报告的一年结果更正报告
Anne Tillmann,Richard Stillenmunkes,Justus G Garweg et al.
Anne Tillmann et al.
Published Erratum
Ophthalmology and therapy. 2026 Feb 28. DOI:10.1007/s40123-026-01319-y 2026